SOD1 and amyotrophic lateral sclerosis: Clinical heterogeneity has also been described in those 20% of familial ALS cases linked to mutations of the superoxide dismutase 1 (SOD1) gene, a genetic defect that exhibits a toxic gain of function that adversely affects motor neurons [2-4].